Target intelligence / Profile preview

Golgin A6 family like 23, pseudogene (GOLGA6L23P)

Target: GOLGA6L23P
Molecular classification: Other, Pseudogene

Overview

Golgin A6 family like 23, pseudogene (GOLGA6L23P) is classified as a pseudogene and does not encode a functional protein[5][6]. Members of the golgin A6 family, when functional, are associated with Golgi apparatus organization, but the pseudogene form lacks known biological activity or disease associations. Pseudogenes are typically not considered therapeutic targets, receptors, enzymes, transporters, or other actionable molecular entities in drug discovery[9][8]. Some pseudogenes have gained attention for their regulatory roles at the RNA level, especially in cancer biology, but there is no evidence that GOLGA6L23P is involved in such processes. Overall, GOLGA6L23P is not a therapeutic target, is properly named, and is best classified structurally as a pseudogene in the noncoding “Other” molecular classification[5][6][9].

Other names: Golgin A6 family like 23, pseudogeneGOLGA6L23P

Mechanism of action

Not applicable (not a drug target)

Biological functions

Most pseudogenes have no direct biological function as they do not encode functional proteinsHowever, some can regulate their coding gene counterparts via mechanisms such as acting as miRNA decoys or forming siRNAs, influencing gene expression epigenetically or post-transcriptionally

Disease associations

Some pseudogenes are implicated in disease through regulatory effects on their parent genes, especially in cancer, but there is no evidence that GOLGA6L23P specifically has a disease role

Beyond the preview

Go deeper on Golgin A6 family like 23, pseudogene (GOLGA6L23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgin A6 family like 23, pseudogene (GOLGA6L23P).

Explore the full profile